Example: confidence

Respiratory syncytial virus 27a - GOV.UK

a significant burden on the cost of care and the economy of all countries (Greenough et al., 2004; Nair et al., 2010). The RSV passive immunisation Synagis® Synagis® solution for injection (Palivizumab) is a humanised monoclonal antibody (IgG11K) produced using recombinant DNA techniques in mouse myeloma host cells.

Tags:

  2010, Burden

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of Respiratory syncytial virus 27a - GOV.UK

Related search queries